Purchase Order 36C24120P0590

Award Date 4/10/20
Potential Completion Date 8/5/21
Potential Value $144K
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Cambridge, MA 02142, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Broad Clinical Laboratories, LLC, a subsidiary of the Broad Institute, provides genetic testing services to the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 1. The single-award indefinite delivery contract (IDC) has a ceiling value of $240,000.00 and a performance period through February 6, 2029. The contract allows for multiple delivery orders, with the initial $270,000.00 firm fixed price order for genetic testing services to...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $59,850 firm fixed price purchase order to Broad Clinical Laboratories, LLC, a subsidiary of the Broad Institute. The contract is for the delivery of 150 clinical whole genome sequencing services, with a completion date of September 30, 2024. Broad Clinical Laboratories is a specialized healthcare services provider that offers genetic testing and clinical genome sequencing to federal agencies, particularly the Department...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 awarded a $270,000 firm fixed price delivery order contract to Broad Clinical Laboratories, LLC of Cambridge, Massachusetts for genetic testing services. The contract has a completion date of February 6, 2029 and was awarded on February 7, 2024. No set-aside designation was used for this award made by the VA to support genetic testing as part of healthcare services for veterans within VISN...
The Broad Institute, Inc., doing business as the Broad Institute of MIT and Harvard, has been awarded a definitive contract valued at $25.7 million by the National Institutes of Health's National Heart, Lung and Blood Institute to scale the Broad Institute's reverse transcription polymerase chain reaction (RT-PCR) process to support testing of over 100,000 samples per day. This contract is part of the Rapid Acceleration of Diagnostics (RADx) Advanced Technology Platforms program, which aims to...
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a $10.9 million firm fixed price purchase order to The Broad Institute, Inc. for serology and virus neutralization testing in support of coronavirus COVID-19 response efforts. Performance will take place at the prime contractor's Cambridge, Massachusetts location through September 2021. No subcontractors or set aside designations were indicated. This award utilizes the prime...
The Broad Institute, Inc. was awarded a $4.4 million definitive cost-no-fee contract by the Centers for Disease Control and Prevention to support applied research addressing the continued public health emergency posed by COVID-19. Under the contract, the Broad Institute will sequence SARS-CoV-2 virus samples and conduct epidemiological analysis in collaboration with two major subcontractors, the Massachusetts General Hospital and the University of Massachusetts Medical School. The subcontractors...
This is a federal contract award valued at $394,227.01 to The Broad Institute, Inc., doing business as Broad Institute of MIT and Harvard, a non-profit biomedical and genomic research organization. The contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), for TAS::75 0885::TAS BIOMEDICAL (APPLIED/EXPLORATORY) services. The contract has no set-aside designation. The Broad Institute frequently partners...
The U.S. Department of Veterans Affairs (VA) awarded a $310,551.59 firm fixed-price purchase order contract to Bioreference Health LLC, a for-profit limited liability company that provides laboratory testing services, including COVID-19 serology testing in support of the Department of Health and Human Services (HHS) and Centers for Disease Control and Prevention (CDC) response efforts. This award has no set-aside designation and is scheduled for completion by May 27, 2024. Bioreference Health...
This federal contract award was issued by the Veterans Integrated Service Network 5 (VISN 5), which is part of the Veterans Health Administration (VHA) under the Department of Veterans Affairs (VA). The contract was awarded to Biofire Diagnostics LLC, a biotech company specializing in syndromic infectious disease testing, to provide COVID-19 laboratory tests and support services. The contract has a period of performance through September 30, 2025 and a ceiling value of $116,640. It is a...
This federal contract award was issued by the Veterans Integrated Service Network 8 (VISN 8), a component of the Department of Veterans Affairs (VA) Veterans Health Administration (VHA), to Biofire Diagnostics LLC, a private sector biotech company. The contract provides for the delivery of molecular diagnostic testing services and products, including COVID-19 testing reagents and equipment, as well as maintenance services for Biofire's infectious disease testing systems. The contract is a...

The Department of Veterans Affairs Veterans Health Administration awarded a $143,800 firm fixed price purchase order to Broad Clinical Laboratories, LLC, a subsidiary of the non-profit Broad Institute, Inc., to provide COVID-19 testing services for VISN1. The contract was awarded on April 10, 2020 and is scheduled to be completed by August 5, 2021. The Broad Institute, Inc. is a prominent biomedical and genomics research organization that has received over $500 million in federal contract awards and $250 million in federal grants to support a variety of scientific initiatives at agencies such as the NIH, CDC, and DoD, including the Trans-Omics for Precision Medicine (TOPMed) program and the BRAIN Initiative Cell Atlas Network. This COVID-19 testing contract was not set aside.

Generated 3/24/24, 4:34 AM